1. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia;Carroll;Canc. Prev. Res.,2011
2. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients;Kanai;Canc. Chemother. Pharmacol.,2013
3. Relationship between the tautomeric structures of curcumin derivatives and their Abeta-binding activities in the context of therapies for Alzheimer's disease;Yanagisawa,2010
4. How does curcumin work with poor bioavailability? Clues from experimental and theoretical studies;Shen;Sci. Rep.,2016
5. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases;Aggarwal;Int. J. Biochem. Cell Biol.,2009